Experience in using immunal in the complex treatment of patients with torpid peptic ulcer

Aim. to provide a rationale for the use of immunal in intractable gastroduodenal peptic ulcers (PU), by studying Helicobacter pylori genotypes and immunological parameters. Subjects and methods. Sixty-eight patients (37 men and 31 women) with torpid PU were examined. A study group comprised 35 patie...

Full description

Bibliographic Details
Main Authors: Yakov Maksimovich Vakhrushev, Anvar Raifovich Balagatdinov, Ya M Vakhrushev, A R Balagatdinov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2010-02-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30534
_version_ 1818772808070594560
author Yakov Maksimovich Vakhrushev
Anvar Raifovich Balagatdinov
Ya M Vakhrushev
A R Balagatdinov
author_facet Yakov Maksimovich Vakhrushev
Anvar Raifovich Balagatdinov
Ya M Vakhrushev
A R Balagatdinov
author_sort Yakov Maksimovich Vakhrushev
collection DOAJ
description Aim. to provide a rationale for the use of immunal in intractable gastroduodenal peptic ulcers (PU), by studying Helicobacter pylori genotypes and immunological parameters. Subjects and methods. Sixty-eight patients (37 men and 31 women) with torpid PU were examined. A study group comprised 35 patients who took immunal as a component of complex eradication therapy; a control group included 33 patients who received complex eradication therapy only. In addition to clinical and endoscopic data, the values of H. pylori genotypes were used to evaluate therapeutic efficiency. Results. The inclusion of immunal into the complex therapy in patients with torpid PU exerts a significant clinical effect in relieving the pain syndrome and dyspeptic symptoms and in accelerating ulcer cicatrization. The disappearance of virulent H. pylori strains was noted during treatment. Recovery of phagocytic, cellular, and humoral immunities is an important result of therapy. Conclusion. The use of immunal as a component of complex therapy for torpid PU is pathogenetically founded and clinically effective.
first_indexed 2024-12-18T10:15:14Z
format Article
id doaj.art-8bda1445397a4da596475c6e601fade1
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-18T10:15:14Z
publishDate 2010-02-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-8bda1445397a4da596475c6e601fade12022-12-21T21:11:19Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422010-02-01822131727561Experience in using immunal in the complex treatment of patients with torpid peptic ulcerYakov Maksimovich VakhrushevAnvar Raifovich BalagatdinovYa M VakhrushevA R BalagatdinovAim. to provide a rationale for the use of immunal in intractable gastroduodenal peptic ulcers (PU), by studying Helicobacter pylori genotypes and immunological parameters. Subjects and methods. Sixty-eight patients (37 men and 31 women) with torpid PU were examined. A study group comprised 35 patients who took immunal as a component of complex eradication therapy; a control group included 33 patients who received complex eradication therapy only. In addition to clinical and endoscopic data, the values of H. pylori genotypes were used to evaluate therapeutic efficiency. Results. The inclusion of immunal into the complex therapy in patients with torpid PU exerts a significant clinical effect in relieving the pain syndrome and dyspeptic symptoms and in accelerating ulcer cicatrization. The disappearance of virulent H. pylori strains was noted during treatment. Recovery of phagocytic, cellular, and humoral immunities is an important result of therapy. Conclusion. The use of immunal as a component of complex therapy for torpid PU is pathogenetically founded and clinically effective.https://ter-arkhiv.ru/0040-3660/article/view/30534helicobacter pyloriintractable gastroduodenal ulcershelicobacter pyloriimmune systemimmunal
spellingShingle Yakov Maksimovich Vakhrushev
Anvar Raifovich Balagatdinov
Ya M Vakhrushev
A R Balagatdinov
Experience in using immunal in the complex treatment of patients with torpid peptic ulcer
Терапевтический архив
helicobacter pylori
intractable gastroduodenal ulcers
helicobacter pylori
immune system
immunal
title Experience in using immunal in the complex treatment of patients with torpid peptic ulcer
title_full Experience in using immunal in the complex treatment of patients with torpid peptic ulcer
title_fullStr Experience in using immunal in the complex treatment of patients with torpid peptic ulcer
title_full_unstemmed Experience in using immunal in the complex treatment of patients with torpid peptic ulcer
title_short Experience in using immunal in the complex treatment of patients with torpid peptic ulcer
title_sort experience in using immunal in the complex treatment of patients with torpid peptic ulcer
topic helicobacter pylori
intractable gastroduodenal ulcers
helicobacter pylori
immune system
immunal
url https://ter-arkhiv.ru/0040-3660/article/view/30534
work_keys_str_mv AT yakovmaksimovichvakhrushev experienceinusingimmunalinthecomplextreatmentofpatientswithtorpidpepticulcer
AT anvarraifovichbalagatdinov experienceinusingimmunalinthecomplextreatmentofpatientswithtorpidpepticulcer
AT yamvakhrushev experienceinusingimmunalinthecomplextreatmentofpatientswithtorpidpepticulcer
AT arbalagatdinov experienceinusingimmunalinthecomplextreatmentofpatientswithtorpidpepticulcer